Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1975 1
1980 1
1981 1
1986 1
1999 1
2002 1
2005 1
2007 2
2008 2
2009 2
2010 2
2011 4
2012 6
2013 4
2014 1
2015 5
2016 7
2017 8
2018 10
2019 7
2020 12
2021 16
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition.
Lew TE, Lin VS, Cliff ER, Blombery P, Thompson ER, Handunnetti SM, Westerman DA, Kuss BJ, Tam CS, Huang DCS, Seymour JF, Roberts AW, Anderson MA. Lew TE, et al. Among authors: thompson er. Blood Adv. 2021 Oct 26;5(20):4054-4058. doi: 10.1182/bloodadvances.2021005083. Blood Adv. 2021. PMID: 34478505 Free PMC article.
Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.
Thompson ER, Gorringe KL, Rowley SM, Wong-Brown MW, McInerny S, Li N, Trainer AH, Devereux L, Doyle MA, Li J, Lupat R, Delatycki MB; LifePool Investigators, Mitchell G, James PA, Scott RJ, Campbell IG. Thompson ER, et al. Breast Cancer Res. 2015 Aug 19;17(1):111. doi: 10.1186/s13058-015-0627-7. Breast Cancer Res. 2015. PMID: 26283626 Free PMC article.
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.
Blombery P, Anderson MA, Gong JN, Thijssen R, Birkinshaw RW, Thompson ER, Teh CE, Nguyen T, Xu Z, Flensburg C, Lew TE, Majewski IJ, Gray DHD, Westerman DA, Tam CS, Seymour JF, Czabotar PE, Huang DCS, Roberts AW. Blombery P, et al. Among authors: thompson er. Cancer Discov. 2019 Mar;9(3):342-353. doi: 10.1158/2159-8290.CD-18-1119. Epub 2018 Dec 4. Cancer Discov. 2019. PMID: 30514704
Cell therapy during machine perfusion.
Thompson ER, Connelly C, Ali S, Sheerin NS, Wilson CH. Thompson ER, et al. Transpl Int. 2021 Jan;34(1):49-58. doi: 10.1111/tri.13780. Epub 2020 Nov 24. Transpl Int. 2021. PMID: 33131097 Free article. Review.
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.
Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, Pertesi M, Voegele C, Mebirouk N, Robinot N, Durand G, Forey N, Luben RN, Ahmed S, Aittomäki K, Anton-Culver H, Arndt V; Australian Ovarian Cancer Study Group, Baynes C, Beckman MW, Benitez J, Van Den Berg D, Blot WJ, Bogdanova NV, Bojesen SE, Brenner H, Chang-Claude J, Chia KS, Choi JY, Conroy DM, Cox A, Cross SS, Czene K, Darabi H, Devilee P, Eriksson M, Fasching PA, Figueroa J, Flyger H, Fostira F, García-Closas M, Giles GG, Glendon G, González-Neira A, Guénel P, Haiman CA, Hall P, Hart SN, Hartman M, Hooning MJ, Hsiung CN, Ito H, Jakubowska A, James PA, John EM, Johnson N, Jones M, Kabisch M, Kang D; kConFab Investigators, Kosma VM, Kristensen V, Lambrechts D, Li N; Lifepool Investigators, Lindblom A, Long J, Lophatananon A, Lubinski J, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Meindl A, Mitchell G, Muir K; NBCS Investigators, Nevelsteen I, van den Ouweland A, Peterlongo P, Phuah SY, Pylkäs K, Rowley SM, Sangrajrang S, Schmutzler RK, Shen CY, Shu XO, Southey MC, Surowy H, Swerdlow A, Teo SH, Tollenaar RA, Tomlinson I, Torres D, Truong T, Vachon C, Verhoef S, Wong-Brown M, Zheng W, Zheng Y, Nevanlinna H, Scott RJ, Andrulis IL, Wu AH, Hopper JL, Couch FJ, Winqvist R, Burwinkel B, Sawyer EJ, Schmidt MK, Rudolph A, Dörk T, Brauch H, Hamann U, Neuhausen SL, Milne RL, Fletcher O, Pharoah PD, Campbell IG, Dunning AM, Le Calvez-Kelm F, Goldgar DE, Tavtigian SV, Chenevix-Trench G. Easton DF, et al. Among authors: thompson er. J Med Genet. 2016 May;53(5):298-309. doi: 10.1136/jmedgenet-2015-103529. Epub 2016 Feb 26. J Med Genet. 2016. PMID: 26921362 Free PMC article.
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blombery P, Lew TE, Dengler MA, Thompson ER, Lin VS, Chen X, Nguyen T, Panigrahi A, Handunnetti SM, Carney DA, Westerman DA, Tam CS, Adams JM, Wei AH, Huang DCS, Seymour JF, Roberts AW, Anderson MA. Blombery P, et al. Among authors: thompson er. Blood. 2022 Feb 24;139(8):1198-1207. doi: 10.1182/blood.2021012775. Blood. 2022. PMID: 34469514 Clinical Trial.
The Emerging Role of Gas Plasma in Oncotherapy.
Dai X, Bazaka K, Richard DJ, Thompson ERW, Ostrikov KK. Dai X, et al. Among authors: thompson erw. Trends Biotechnol. 2018 Nov;36(11):1183-1198. doi: 10.1016/j.tibtech.2018.06.010. Epub 2018 Jul 20. Trends Biotechnol. 2018. PMID: 30033340 Review.
Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P, Thompson ER, Prince HM. Blombery P, et al. Among authors: thompson er. Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. doi: 10.1097/PRS.0000000000005570. Plast Reconstr Surg. 2019. PMID: 30817557 Review.
A study of pregnancy rates in "cleared" male factor couples.
Godart ES, Shin DH, Christensen E, Thompson ER, Turek PJ. Godart ES, et al. Among authors: thompson er. Transl Androl Urol. 2021 Feb;10(2):620-625. doi: 10.21037/tau-20-1240. Transl Androl Urol. 2021. PMID: 33718064 Free PMC article.
93 results